Key result
Hot-spot TNNT2 mutations in HCM link to ~5-fold greater arrhythmic burden versus sporadic mutations.
Why the study?
The pathogenesis of atrial myopathy in HCM remains poorly investigated and no specific association with genotype has been identified.
Does the specific type of TNNT2 mutation (hot-spot vs. sporadic) determine the pathogenesis and occurrence of atrial fibrillation in hypertrophic cardiomyopathy?
Observational (n=45)
Yes
Does the specific type of TNNT2 mutation (hot-spot vs. sporadic) determine the pathogenesis and occurrence of atrial fibrillation in hypertrophic cardiomyopathy?
Specific TNNT2 hot-spot mutations are associated with a higher prevalence of atrial fibrillation in HCM due to increased atrial myofilament calcium sensitivity, highlighting a genotype-driven arrhythmogenic mechanism.
Hot-spot TNNT2 mutations may flag higher arrhythmic risk in HCM; findings are hypothesis-generating and require prospective validation.
Atrial dilation and atrial fibrillation (AF) are common in Hypertrophic CardioMyopathy (HCM) patients and associated with a worsening of prognosis. The pathogenesis of atrial myopathy in HCM remains poorly investigated and no specific association with genotype has been identified. By re-analysis of our cohort of thin-filament HCM patients (Coppini et al. 2014) AF was identified in 10% of patients with sporadic mutations in the cardiac Troponin T gene ( TNNT2 ), while AF occurrence was much higher (25–75%) in patients carrying specific “hot-spot” TNNT2 mutations. To determine the molecular basis of arrhythmia occurrence, two HCM mouse models expressing human TNNT2 variants (a “hot-spot” one, R92Q, and a “sporadic” one, E163R) were selected according to the different pathophysiological pathways previously demonstrated in ventricular tissue. Echocardiography studies showed a significant left atrial dilation in both models, but more pronounced in the R92Q. In E163R atrial trabeculae, in line with what previously observed in ventricular preparations, the energy cost of tension generation was markedly increased. However, no changes of twitch amplitude and kinetics were observed, and there was no atrial arrhythmic propensity. R92Q atrial trabeculae, instead, displayed normal ATP consumption but markedly increased myofilament calcium sensitivity, as previously observed in ventricular preparations. This was associated with reduced inotropic reserve and slower kinetics of twitch contractions and, importantly, with an increased occurrence of spontaneous beats and triggered contractions that represent an intrinsic arrhythmogenic mechanism promoting AF. The association of specific TNNT2 mutations with AF occurrence depends on the mutation-driven pathomechanism (i.e., increased atrial myofilament calcium sensitivity rather than increased myofilament tension cost) and may influence the individual response to treatment.
No takes yet. Share an insight, caveat, or question.
Pioner et al. (2022) conducted an observational in Hypertrophic Cardiomyopathy (n=45). Hot-spot TNNT2 mutations vs. Sporadic TNNT2 mutations was evaluated on Overall arrhythmic burden (p=0.0281). Hypertrophic cardiomyopathy patients carrying hot-spot TNNT2 mutations had a significantly higher overall arrhythmic burden (48.6%) compared to those with sporadic mutations (10%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Hypertrophic cardiomyopathyMore from Frontiers in Physiology